The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. SUBSCRIBE to our new newsletter at www.bioprocessonline.com/bob. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, and regulatory challenges you’ll face as you navigate your company from an idea to success in the clinic. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The Business of Biotech is p ...
…
continue reading
Perspectives from the cutting edge of biotech and pharma. The fast-changing world of biopharma places a premium on trusted market insights from industry experts who can turn change into a competitive advantage. Stay ahead of the curve with our latest podcast series. Lead today. Define tomorrow.
…
continue reading
Evaluating Biopharma taps into the insight and experience of biopharmaceutical leaders so today’s decision makers can leverage their knowledge, learn from their successes, and avoid repeating similar mistakes. This series offers a new guest and moderator with each episode and aims to equip executives and science leaders with the necessary information to make better business and process decisions. The Evaluating Biopharma podcast is a reproduction of content originally presented at recent Eva ...
…
continue reading
BioBoss is a podcast about leadership in the biopharma community. Hear directly from the founders and CEOs of today's most innovative companies. Listen in as Wyant Simboli Principal and branding veteran John Simboli poses the questions "What drives you? How do you create change? Why should people care?" to biopharma leaders and hear insights on this rapidly developing field.
…
continue reading
The Syneos Health Podcast Series dissects some of the most complex issues biopharma leaders are facing today. Our clinical and commercial experts provide time-tested solutions, as well as perspectives on the news of the day. Hosted by Jeff Stewart, a long-time industry consultant who has advised biopharma leaders on licensing, mergers and acquisitions, pricing and market access, commercialization and go-to-market strategies, each episode explores the challenges and considerations involved wi ...
…
continue reading
Citeline places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge and insight, by providing the perfect combination of news and information together with penetrating insight and analysis. Citeline is a leader in the field of healthcare industry information.
…
continue reading
An exploration of the digital trends and technology driving change in the biopharmaceutical industry. In-depth conversations with industry leaders at the forefront of transformation.
…
continue reading
For biopharma pros seeking insightful discussions and a deeper understanding of the pharma world, join Dr. Na-Ri Oh and Ian Wendt as they talk with industry leaders and luminaries to delve into biotechnology, pharmaceuticals, and healthcare. RealPharma podcast aims to challenge your viewpoints, deepen your understanding of the pharma world beyond the headlines, and explore emerging trends in medical innovation.
…
continue reading
Biopharma and medtech explained. Every week, journalists from Fierce Biotech, Fierce Medtech, and Fierce Pharma recount the latest industry trends and why they matter. We'll analyze the week's biggest business news, from mergers and marketing to drug R&D and device development. Available every Friday morning.
…
continue reading
Tune in to BioCentury’s in-depth conversations with global leaders who are advancing the future of medicine. Join our Senior Editors in face-to-face discussions with scientific KOLs, top executives, VCs, and key policymakers, dissecting the most urgent public health issues. The BioCentury Show is THE only place where BioCentury’s experts join top innovators and global influencers to show how science is being turned into medicine. Don't miss this event, every two weeks, now available as a vid ...
…
continue reading
BioPharma EH&S Podcast. The latest discussion on potent compound safety, occupational toxicology, industrial hygiene, and compliance management software. To submit questions or comments to the podcast email affygility@gmail.com or call our listener voicemail line at 206-984-3214.
…
continue reading
Your trusted partner in pharmaceutical manufacturing. We specialize in high-quality, innovative pharmaceutical products, ensuring healthcare solutions that meet global standards.
…
continue reading
Duane Schulthess is the CEO of Vital Transformation, host and producer of Vital Health Podcast. Vital Transformation understands the implications of new medical procedures, technologies and regulations. We measure their impact upon treatment pathways and the biopharma innovation ecosystem in collaboration with health care professionals, researchers, and regulators. Through our web platform and client network, we are able to communicate our findings with international decision makers and stak ...
…
continue reading
One-on-one with medical innovators Breakthrough medicines, billion-dollar deals, spectacular clinical successes and crushing failures all play a part in biopharma’s dynamic story. Developers make scientific advancements with the potential to change everything, only to face regulatory conundrums and ever-fluctuating markets. BioWorld tracks key events in the fast-moving sector every business day. Now, the BioWorld Insider podcast lets you hear directly from the movers and shakers whose collec ...
…
continue reading
Here at Drug Discovery World (DDW) we've been publishing articles written by leading experts in the Drug Discovery, Pharmaceutical, and BioPharmaceutical industries for over 20 years. DDW has grown as a quarterly business review of drug discovery and development, and now we've created this podcast to allow you to listen to our articles on the go. In our journal and this podcast, we cover topics surrounding: drug discovery; drug development; business; chemistry; enabling technologies; informa ...
…
continue reading
AI For Pharma Growth is the podcast from pioneering Artificial Intelligence entrepreneur Dr. Andree Bates created to help Pharma, Biotech and other Healthcare companies understand how the use of AI-based technologies can easily save them time and grow their brands and company results. This show blends deep experience in the sector with demystifying AI for biopharma execs from biotech start-ups right through to big pharma. In this podcast, Dr Andree will teach you the tried and true secrets t ...
…
continue reading
Join Nancy Donohoo’s bi-weekly podcast, Talk at the Top, and get to know the key influencers in life sciences and healthcare who are positively impacting patients, providers, consumers and the industry itself! Nancy’s guests include groundbreakers and executives from across the healthcare spectrum: CEOs, physician executives, medical affairs and scientific leaders, venture capital and private equity investors, academics and entrepreneurs. This is your front row ticket to discussions on innov ...
…
continue reading
Contract Pharma is the premier media outlet linking contract service providers and their pharma/biopharma sponsors. Rooted in our legacy print publication—issued 9 times per year—the Contract Pharma brand continues to evolve across its digital media platforms through ContractPharma.com, Contract Pharma Direct eNewsletters, and social media channels.
…
continue reading
Back Bay Life Science Advisors brings you expert insights from our advisors and investment bankers in the world of BioPharma & MedTech. On this podcast, you’ll hear from our experts in life science development, commercialization, and investment banking, scientific investigators, biotech and medtech executives, physicians, and strategists who excel at guiding global life sciences companies and their investors through complex decisions. Join us for insights generated from in-depth scientific, ...
…
continue reading
From sales to medical affairs, we will help you break into and navigate your career in the biopharma industry!
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Rare Insights: Uncovering The Future Of Rare Disease Treatments
Know Rare (Taren Grom, Liz Kay, Kaitlyn Taylor, Nina Wachsman, and DNA Today’s Kira Dineen)
On “Rare Insights” we bridge the gap between those living with rare diseases and the biopharmaceutical industry. Know Rare amplifies the voices of individuals with rare conditions, providing invaluable perspectives to accelerate therapeutic solutions. Join us as we dive deep into the complexities of rare diseases, exploring real-world insights from passionate industry leaders. Together, we navigate the unknowns and unlock the potential for groundbreaking treatments. Because in this journey, ...
…
continue reading
In conversation with APAC's nutrition research pioneers. A podcast brought to you by the team behind NutraIngredients-Asia.com.
…
continue reading
Kurt Wehrle is a Chicago-based enterprising worldwide business pioneer with 20+ long periods of assorted and progressive P&L management in top-notch Biopharma, Medical Device, and Diagnostic organizations. Kurt Wehrle has a demonstrated history of creating multi-layered worldwide systems, building frameworks, changing business, extending topographies, and creating on the web capacities to essentially expand income and EBITDA.
…
continue reading
On this podcast, you'll find interviews with high-performing successful individuals in Life Sciences. On a weekly basis, we cover their proven methods, principles, strategies, and mindsets to implement new technologies that scale to meet the needs of people in our world.
…
continue reading
HedgeD, with a capital “D” for emphasis, brings listeners topical content from both sides of the ledger – the long side and the short side. In each episode, co-hosts Mark Yusko, Cory Lester and Andrew Schmeelk take a deep dive into an investment theme or concept, typically with the help of an expert guest from Morgan Creek’s expansive global network.
…
continue reading
Welcome to AI Uncovered, a podcast for technology enthusiasts that explores the intersection of generative AI, machine learning, and innovation across regulated industries. With the AI software market projected to reach $14 trillion by 2030, each episode features compelling conversations with an innovator exploring the impact of generative AI, LLMs, and other rapidly evolving technologies across their organization. Hosted by Executive VP of Product at Yseop, Tim Martin leads a global team an ...
…
continue reading
Your Brain On... is a podcast by Learning and Development professionals for Learning and Development professionals. Every day, Salience Learning combines the science of learning with expertise in the business of science to help solve the biopharma industry's most complex business challenges. Listen as hosts Karen Foster and Krista Gerhard discuss the latest in cognitive science and learning strategies as they relate to the ever-evolving healthcare industry. In other words: Your Brain On... g ...
…
continue reading
This podcast aims to bring you a daily summary of the most relevant news in Pharma and BioTech. Check our website at: https://www.buzzsprout.com/2189790
…
continue reading
Physician NonClinical Careers is presented to inspire, encourage, and teach physicians how to pivot to a new career. John Jurica will present topics important to pivoting physicians and interview experts and physicians who have completed their career pivots.
…
continue reading
Join us as we tackle the essential factors that drive successful commercial products. Our team interviews industry thought leaders to explore regulatory compliance, market trends, and innovation. Stay ahead in this dynamic industry.
…
continue reading
Welcome to BIOTECH NATION !!! With understandable interviews requiring no background in science, BTN attracts a wide global audience. From everyday people looking for hope in treatments in development, to bioentrepreneurs interested in the experience of their fellow travelers, to venture capitalists looking for possibilities in cutting-edge breakthroughs, to scientists simply interested in the work of others, BioTech Nation is the voice of human endeavor, driving science to new realities for ...
…
continue reading
Lean By Design takes a deep look into the complex, ever-changing world of the biotech, pharma, and related industries from the lens of workflow design. Come along as our hosts, Oscar and Lawrence, explore the relationship between the people and workflow design by chatting with industry leaders. These innovators will share their stories about the risks they’ve taken in re-designing solutions to often complex problems. Join us to learn from industry experts as they deliver practical tips and t ...
…
continue reading
Welcome to the Lattice podcast, the official podcast for 3DHEALS. This is where you will find fun but in-depth conversations (by founder Jenny Chen) with technological game-changers, creative minds, entrepreneurs, rule-breakers, and more. The conversations focus on how to use 3D technologies, like 3D printing and bioprinting, AR/VR, and In silico simulation, to reinvent healthcare and life sciences. This podcast will include AMA (Ask Me Anything) sessions, past Instagram Live interviews, pre ...
…
continue reading
Welcome to our podcast where we dive into the dynamic world of pharmaceutical careers with a sprinkle of fun and a dash of humor! With nearly a decade of experience in medical affairs, a bioscience master’s degree, and a background in medcomms, I'm here to make your journey into pharma exciting and accessible. Whether you’re thinking about a career change, making the leap from an agency to pharma, or coming from a clinical background or bioscience education, this podcast is for you. From my ...
…
continue reading
The lastest news in AI and Life Sciences
…
continue reading
Every medicine in your pharmacy has a human story behind it. Real people doing real work and living real lives. We all have romantic ideas about scientists working late into the evening or doctors dropping everything to answer a phone call about a patient. You can almost envision the moment when one of those researchers finally solves an intellectual puzzle and leaps into action. Their eyes go from an empty stare to an alert laser-like focus. They sit a bit taller and start to read frantical ...
…
continue reading
The TechCrunch Live Podcast helps founders build better venture backed businesses. Each week, we chat with experienced entrepreneurs and investors on their past wins and losses — particularly the pitches that helped build the business at an early stage.
…
continue reading
Weekly podcast exploring China's business and financial sectors from a legal perspective, brought to you by China Law & Practice. Hosted by Vincent Chow.
…
continue reading
A weekly live audience show featuring the people building and funding companies that are extending healthy human lifespan. Join us Thursdays on Clubhouse and check the show schedule on longevitybiotechshow.com Hosted by Nathan Cheng (founder @ Longevity Marketcap // Longevity List) and Robert Ziman (Cohen Lab).
…
continue reading
Join us as we swap ideas with thinkers, innovators and doers from around the world and around L.E.K. Presented by consulting powerhouse L.E.K. Consulting (www.lek.com), Insight Exchange™ is a new forum dedicated to the free and open exchange of the most interesting, important, and urgent ideas in the world of business. From the farthest-reaching environmental issues to innovations in retail, industrials, and healthcare, every installment of Insight Exchange™ invites luminaries to tell us wha ...
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Biopharma Dive: Your Daily Dose of Pharma and Biotech News
3:29
3:29
Play later
Play later
Lists
Like
Liked
3:29
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. Steward Health is closing two Ohio hospitals and a Pennsylvania facility due to financial reasons, drawing criticism from healthcare workers and unions. McLaren Health Care in Michigan is facing disruptions from a ransomwa…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Insights on Biopharma Success and Innovation - Tim Glennon
44:05
44:05
Play later
Play later
Lists
Like
Liked
44:05
Scaling Innovations in Life Sciences: An Interview with Tim Glennon | Life Science Success In this episode of Life Science Success, host Don interviews Tim Glennon, the principal owner of Illumination Strategy Group. With more than 26 years of experience in the pharmaceutical industry, Tim shares his journey, starting from his early career at Bayer…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
What Chevron’s overturn means for biopharma
25:15
25:15
Play later
Play later
Lists
Like
Liked
25:15
For the last 40 years, when federal legislation was ambiguous or left an administrative gap, courts were required to defer to the interpretation of agencies. This stipulation, called the Chevron deference, gave agencies room to advance their regulatory priorities. The Supreme Court overturned the doctrine in June, bringing significant implications …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
The Realities of Corporate Life in Biopharma: What You Need to Know!
19:18
19:18
Play later
Play later
Lists
Like
Liked
19:18
Send us a Text Message. In this episode of The Agency Advantage, I delve into what it's truly like to work in a corporate environment, specifically within a large biopharma company. Aimed at professionals looking to pivot from academia, smaller companies, or other sectors like medical practice or pharmacy, the discussion highlights the complexities…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
0118. Transformative Strategies for Scaling Operations in Biopharma Part 2
13:52
13:52
Play later
Play later
Lists
Like
Liked
13:52
Send us a Text Message. Ever wondered how continuous improvement can propel your organization's growth to new heights? In this episode of Lean by Design, host Oscar Gonzalez delves into innovative strategies drawn from recent projects. Discover how you can transform data into meaningful metrics that drive success and ensure everyone is aligned with…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
AI Revolution: Transforming Biopharma with Andree Bates
51:28
51:28
Play later
Play later
Lists
Like
Liked
51:28
Summary Dr. Andrée Bates, a pioneering force in the realm of artificial intelligence within the pharmaceutical industry, shares insights on the evolving role of AI in pharma, the future of healthcare innovation, and her advocacy for women in leadership. She discusses the early days of AI in pharma, the challenges faced, and the evolution of AI term…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Priceless Advice From An Expert In The BioPharma Industry
33:28
33:28
Play later
Play later
Lists
Like
Liked
33:28
Learn the business and management skills you need by enrolling in the University of Tennessee Physician Executive MBA program at nonclinicalphysicians.com/physicianmba. Get the FREE GUIDE to 10 Nonclinical Careers at nonclinicalphysicians.com/freeguide. Get a list of 70 nontraditional jobs at nonclinicalphysicians.com/70jobs. =============== Dr. Mi…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Joe Panetta – Policy Impacts on California Biopharma
27:30
27:30
Play later
Play later
Lists
Like
Liked
27:30
With the continuing pressure placed upon the US biopharma sector from Washington DC, how is the California biopharma ecosystem, arguably the leading hub for innovative biotech worldwide, responding? In this Vital Health Podcast, we speak with Joseph Panetta to discuss this issue. Joe is the President & CEO of Biocom California, an organization repr…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
The Crucial Role of HEK293 DNA Quantification in Biotherapeutics [Sponsored by Bio-Rad Laboratories]
13:42
13:42
Play later
Play later
Lists
Like
Liked
13:42
Biotherapeutics are transforming healthcare for over 350 million patients globally, tackling everything from cancer and diabetes to rare diseases. Human embryonic kidney (HEK) 293 cells play a key role in the manufacturing of many of these life-changing products. However, they are not without their challenges. In this episode of The Top Line, spons…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Empowering the Patient Voice: A Deep Dive into Advocacy with Stacey Tinianov
49:26
49:26
Play later
Play later
Lists
Like
Liked
49:26
In this episode, Na-Ri and Ian interview Stacey Tinianov, an independent patient advocate and founder of Advocates for Collaborative Education. They discuss the importance of patient advocacy, the role of digital health, and the future of patient engagement. Stacey shares her personal journey into patient advocacy and highlights the gaps in knowled…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
mRNA Upstarts With Radar Therapeutics' Sopha Lugo and Eerik Kaseniit, Ph.D.
1:03:07
1:03:07
Play later
Play later
Lists
Like
Liked
1:03:07
We love to hear from our listeners. Send us a message. Guest co-host Anna Rose Welch of Advancing RNA fame joins us on this week’s Business of Biotech podcast for a conversation with the leaders of RNA upstart Radar Therapeutics. The company’s co-founders, Eerik Kaseniit, Ph.D. (CSO & President) and Sophia Lugo (CEO), are making waves in the mRNA t…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
#3 Transformative Cell and Exosome-Based Therapies with Capricor Therapeutics
20:01
20:01
Play later
Play later
Lists
Like
Liked
20:01
In this episode of "Rare Insights," host Taren Grom sits down with Dr. Linda Marbán, Chief Executive Officer at Capricor Therapeutics, to discuss groundbreaking advancements in the treatment of Duchenne muscular dystrophy and other rare diseases through innovative cell and exosome-based therapies. Dr. Marbán shares her journey in the biotechnology …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Scrip's Five Must-Know Things - 26 August 2024
14:15
14:15
Play later
Play later
Lists
Like
Liked
14:15
Audio roundup of selected biopharma industry content from Scrip over the business week ended 23 August 2024. In this episode: CMS’s price reveal better than expected?; new diabetes risk data for Zepbound; can J&J’s lung cancer combo stand up to Tagrisso?; new recruits for BioMarin leadership; and Glenmark’s shifting revenues.https://scrip.citeline.…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Logistics & Leadership in Life Sciences: A Chat with Artug Acar
26:42
26:42
Play later
Play later
Lists
Like
Liked
26:42
In this episode of Life Science Success, host Don interviews Artug Akar, Chief Operating Officer at Mercury, about his journey from mechanical engineering in Turkey to leading logistics transformation in the life sciences and healthcare sectors. Artug shares insights on the complexities and challenges of logistics, particularly cold chain managemen…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Pharma and Biotech Daily: Stay Informed on the Latest Industry News
2:49
2:49
Play later
Play later
Lists
Like
Liked
2:49
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.Leqembi, a new biotech drug, has been approved in the UK, but reimbursement may not follow due to concerns about the cost to the NHS. The FDA defended its med device chief's tenure after ethics concerns were raised. Employe…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Transforming Health Communications: Insights from Virginia Amann
26:51
26:51
Play later
Play later
Lists
Like
Liked
26:51
Join us at the International 2024 BIO conference as host Duane Schulthess sits down with Virginia Amann, CEO of the Entente Network. Discover how Virginia has led her firm to become a global leader in strategic communications, crisis management, and behavior science. They discussed the firm's mission to secure positive outcomes for clients, the imp…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Popular Episode - Bob Nelsen on AI, China and the IRA
35:33
35:33
Play later
Play later
Lists
Like
Liked
35:33
This is a previously recorded episode of The BioCentury Show from February 22, 2024. Subscribe to this channel to listen to each new episode. Visit TheBioCenturyYouTube.com to access and watch all prior episodes. In a wide-ranging conversation with BioCentury, Bob Nelsen, co-founder and managing director of Arch Venture Partners, said he is excited…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
August 2024 Datamonitor Healthcare Podcast: The Colorful Landscape of Therapeutic Psychedelics
15:22
15:22
Play later
Play later
Lists
Like
Liked
15:22
Following the recent FDA rejection of MDMA therapy for PTSD, Emma and Flora discuss the future role of psychedelics in the treatment of mental health disorders. Content warning: This episode does contain mentions of sexual assault and abuse.Apple Podcasts - https://podcasts.apple.com/us/podcast/pharma-intelligence-podcasts/id923189836Google Podcas…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
How technology is impacting drug discovery
17:31
17:31
Play later
Play later
Lists
Like
Liked
17:31
This is the latest episode of the free DDW narrated podcast, titled "How technology is impacting drug discovery", which covers two articles written for Volume 24 – Issue 1, Winter 2022/2023 of DDW. They are called: AI is critical to solving new complexities in drug discovery and The push towards lab automation in biopharma. In the first article, An…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Pharma and Biotech Daily: August 21, 2024 - Leadership Changes, FDA Setbacks, and Industry Updates
1:58
1:58
Play later
Play later
Lists
Like
Liked
1:58
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. Biopharma news on August 21, 2024 saw changes in Biomarin's C-suite, with Greg Friberg and James Sabry taking over R&D and business development. BridgeBio launched GondolaBio for rare disease drug programs, while Regener…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Can the Mapping of Human Biology Lead to Better Drugs? Dr. Chris Gibson, Co-Founder & CEO Recursion Pharmaceuticals
21:42
21:42
Play later
Play later
Lists
Like
Liked
21:42
Dr. Chris Gibson, the co-founder and CEO of Recursion Pharmaceuticals in Salt Lake City. We talk about their efforts to map ALL of human biology, and how this mapping will lead to better drugs.By Moira Gunn
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Decoding Gen AI’s Potential to Drive More Effective Clinical Trials
31:32
31:32
Play later
Play later
Lists
Like
Liked
31:32
AI is seemingly everywhere now in our lives, including healthcare and drug discovery and development. AI certainly has the potential to enable major advances than development of more effective and safe medical products. And in fact, GenAI has already been successfully used in drug discovery. But are we fully leveraging the current AI yet in practic…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Pharma and Biotech Daily: Stay Informed on the Latest Industry Updates
2:26
2:26
Play later
Play later
Lists
Like
Liked
2:26
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.J&J has acquired heart failure implant maker V-Wave for up to $1.7 billion, while Medtronic reiterates its unchanged diabetes strategy despite a partnership with Abbott. Histosonics secured $102 million for a noninvasive …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
E127 | Who is using your face? Find out with AI
26:56
26:56
Play later
Play later
Lists
Like
Liked
26:56
In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by IdentifAI founders Justin Marciano and Paul Vann to explore the deep fake challenge and the innovative solutions they are developing. The pair share their unique backgrounds and motivations for founding the company, emphasising the critical need to address the growing threat of …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
How to Be Happy Writing, Teaching and Limiting Clinical – A PNC Classic from 2018
33:01
33:01
Play later
Play later
Lists
Like
Liked
33:01
Learn the business and management skills you need by enrolling in the University of Tennessee Physician Executive MBA program at nonclinicalphysicians.com/physicianmba. Get the FREE GUIDE to 10 Nonclinical Careers at nonclinicalphysicians.com/freeguide. Get a list of 70 nontraditional jobs at nonclinicalphysicians.com/70jobs. =============== Dr. Su…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Pharma and Biotech Daily: Your Essential Guide to Industry Updates
2:30
2:30
Play later
Play later
Lists
Like
Liked
2:30
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.On August 19, 2024, the FDA approved the first at-home syphilis test by NowDiagnostics, providing quick results with just a drop of blood. Dupont acquired Donatelle Plastics for $313 million, while Boston Scientific resub…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Bioprinting – An Innovative Tool That Is Revolutionizing Drug Discovery
41:14
41:14
Play later
Play later
Lists
Like
Liked
41:14
Keith Murphy, co-founder of Organovo, discusses the growing potential of bioprinting and how the company is using its technologies to study and develop treatments for inflammatory bowel disease (IBD).By Citeline
…
continue reading
The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. The chosen news highlights this week all feature advances in drug development in oncology indications and reflect the breadth of therapeutic…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Steering Through Setbacks with AVEO Oncology's Michael Bailey
58:06
58:06
Play later
Play later
Lists
Like
Liked
58:06
We love to hear from our listeners. Send us a message. For all the drug commercialization successes he's played a leading hand in during his tenures at GSK, Genentech, and ImClone—Androderm, Augmentin, necitumumab, and Erbitux among them—Michael Bailey concedes that he's likely better known for his failures. After hearing his stories on this episod…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Pharma and Biotech Daily: Cutting through the noise in the world of healthcare.
2:33
2:33
Play later
Play later
Lists
Like
Liked
2:33
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.Medicare has revealed the results of drug price negotiations, showing $6 billion in savings for taxpayers from talks involving drugs like Eliquis and Xarelto. Lilly has opened an R&D hub in Boston, while Ovid and Lexicon ar…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Scrip's Five Must-Know Things - 19 August 2024
15:10
15:10
Play later
Play later
Lists
Like
Liked
15:10
Audio roundup of selected biopharma industry content from Scrip over the business week ended 16 August 2024. In this episode: Merck & Co. steps into CD19 bispecific space; gene therapy patients rise, but slowly; Madrigal’s Rezdiffra plans; Korean biopharma financing recovering?; and approvals to watch out for in Q3.https://scrip.citeline.com/SC1507…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Interview Dr. Mohit Chhaya: BellaSeno
1:10:19
1:10:19
Play later
Play later
Lists
Like
Liked
1:10:19
This Saturday, I had a pleasant visit from the CEO and co-founder of BellaSeno, Dr. Mohit Chayya, a startup located in Leipzig, Germany, working on 3D-printed implants for both soft tissues and bone. We had some nice green tea and pastries and chatted about a slew of things from his worldly experiences from residing in four countries and Game of Th…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Drug Fix: What We Learned From The First Batch Of Medicare Negotiated Drug Prices
35:44
35:44
Play later
Play later
Lists
Like
Liked
35:44
Pink Sheet reporter and editors discuss the take-aways from the landmark first Medicare negotiated drug prices and what additional information remains outstanding.More On These Topics From The Pink SheetMedicare Negotiation Announcement: Discounts From List Price Up To 79%, But Net Savings Unclear: https://pink.citeline.com/PS155128/Medicare-Negoti…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Michael Penlington - Impact of AI and New Standards in Clinical Trials
43:19
43:19
Play later
Play later
Lists
Like
Liked
43:19
We welcome Michael Penlington to AI Uncovered. Michael has been working in Pharma for his entire career including roles in leading development of Vaccines and Clinical reporting at Novartis, as well as Senior Director roles of Science writing, Global Medical Writing and Medical Writing Center of Excellence at GSK. Most recently, Michael has taken o…
…
continue reading
The TROP2 antibody-drug conjugate race has heated up among three Big Pharma companies: Gilead Sciences, AstraZeneca and Merck. Fierce Pharma’s Angus Liu recently took a deep dive into the three TROP2 front-runners. In a feature article, he examined the strengths and potential challenges facing each candidate, as well as the considerations behind th…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Pharma and Biotech Daily: The Latest in Gene Therapy, Drug Pricing, and Cancer Research
4:24
4:24
Play later
Play later
Lists
Like
Liked
4:24
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.Evotec is exiting the gene therapy field and cutting jobs due to a slowdown in research spending. Merck has made a $700 million bet on an antibody drug for immune diseases, while Lilly has opened a new R&D hub in Boston. Ov…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Biotech Buzz: The Latest News and Trends in Pharma and Biotech
2:41
2:41
Play later
Play later
Lists
Like
Liked
2:41
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.The FDA recently approved Ascendis' drug for a rare endocrine condition, while rejecting MDMA as a therapy aid for PTSD. Pfizer also presented data supporting a case for an RSV shot for immunocompromised adults. Zepbound sh…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
【3分で解説 世界のファーマ】第20回 欧州心臓病学会 注目の新薬候補は (Japanese-language podcast)
3:03
3:03
Play later
Play later
Lists
Like
Liked
3:03
世界の製薬ビジネスを伝える「Scrip」と、各国で変化する製薬関連の規制に特化した「Pink Sheet」。普段は英語で発信する2つのオンラインメディアから、今注目の話題を日本語で短くまとめてお届けします。今回取り上げた記事はこちらWhat To Look Out For At ESC 2024https://scrip.citeline.com/SC150740/What-To-Look-Out-For-At-ESC-2024By Citeline
…
continue reading
![Artwork](/static/images/128pixel.png)
1
One Company, Two Different Drugs - It's All About Glucose - Too Much and Too Little! Nevan Charles Elam, Founder & CEO, Rezolute
18:52
18:52
Play later
Play later
Lists
Like
Liked
18:52
Glucose is essential for life. And the insulin we produce is designed to leave just the right of amount in our bodies for healthy functioning. Thus, when we underproduce insulin - or we overproduce it - the results can be devastating. Nevan Charles Elam, Founder and CEO of Rezolute, tells us about their work to treat the “diabetic eye condition”, D…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Sustainable By Design: Thermo Fisher's Meron Mathias On ESG Compliance And The Competitive Edge
29:47
29:47
Play later
Play later
Lists
Like
Liked
29:47
Compliance with environmental sustainability goals is no longer optional for medtech companies serving global healthcare markets. Thermo Fisher has made it a mission to be a leader in thought and actions in meeting Scope 1, 2 and 3 needs. Corporate VP and head of sustainability Meron Mathias explains the company's sustainability aims and methods, f…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Innovations and Insights: Your Daily Dose of Pharma and Biotech News
4:29
4:29
Play later
Play later
Lists
Like
Liked
4:29
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. Steward, a bankrupt healthcare organization, is set to sell its physician group to a private equity firm for $245 million. Kaiser's operating margin has risen to 3.1% in the second quarter, indicating a strong performance …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
E126 | The impact of RAG and LLMs on data processing and decision-making
25:51
25:51
Play later
Play later
Lists
Like
Liked
25:51
In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by Vinoth Nageshwaran, a leading data engineer currently working at Business Insider. Vinoth discusses the challenges of large language models (LLMs) like ChatGPT, which often hallucinate or generate inaccurate information due to their lack of true understanding and ability to veri…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
0117. Transformative Strategies for Scaling Operations in Biopharma
19:29
19:29
Play later
Play later
Lists
Like
Liked
19:29
Send us a Text Message. Ever wondered how to supercharge your company's operations without expanding your team? In this episode of Lean by Design, host Oscar Gonzalez reveals innovative strategies from a recent project with a dynamic 100-person company. Discover how you can enhance workflow efficiency by reimagining and optimizing your existing dat…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
The Amazing Field of Life Insurance Medicine - A PNC Classic from 2018
38:27
38:27
Play later
Play later
Lists
Like
Liked
38:27
We have our new episode sponsor… It is Dr. Armin Feldman’s Prelitigation Pretrial Medical Legal Consulting Coaching Program, which will teach you to build your own nonclinical consulting business as a valued consultant to attorneys without doing med mal cases or expert witness work. You will apply your medical education and experience to generate a…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Pharma and Biotech Daily: Your Quick Update on Industry News and Trends
4:02
4:02
Play later
Play later
Lists
Like
Liked
4:02
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.The FDA approved Ascendis' drug for a rare endocrine condition, while rejecting MDMA as a therapy aid for PTSD. Pfizer presented new data on their RSV shot for immunocompromised adults. Halda, a startup, raised $126 milli…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Scrip's Five Must-Know Things - 13 August 2024
15:29
15:29
Play later
Play later
Lists
Like
Liked
15:29
Audio roundup of selected biopharma industry content from Scrip over the business week ended 9 August 2024. In this episode: Amgen positions for obesity and diabetes; BMS returns TIGIT asset in pipeline reshuffle; is Kerendia the next jewel in Bayer’s crown?; Japan pharma firms cut jobs; and Sun Pharma seeks GLP-1 partner.https://scrip.citeline.com…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Balancing Claims and Compliance in Healthcare Marketing, with Group 31 CEO Crystal Weber
29:20
29:20
Play later
Play later
Lists
Like
Liked
29:20
Creating labeling claims that support business goals without getting into compliance issues can be a tough sea to navigate. Today, join Kymanox Director of Regulatory Affairs Stefanie Johns as she sits down with Crystal Weber, CEO of Group 31, in this episode on The Factor, to discuss the complexities of marketing in the highly regulated healthcare…
…
continue reading
The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. The news highlights this week all centre around significant US Food and Drug Administration (FDA) regulatory decisions, including new approv…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Leading From Within with ISCT & Kiji's Miguel Forte, M.D.
59:37
59:37
Play later
Play later
Lists
Like
Liked
59:37
We love to hear from our listeners. Send us a message. He's been a big pharma executive. He's a multi-time biotech founder and current biotech CEO. He was once a regulator. He's a physician. He serves on multiple boards. And as of this summer, he's president of one of the most influential global organizations dedicated to the advance of cell and ge…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Why Purpose Is Key To Driving CHC Growth, With Haleon’s Bas Vorsteveld
40:19
40:19
Play later
Play later
Lists
Like
Liked
40:19
Since becoming a standalone consumer health company, Haleon has been driving awareness of public health issues such as chronic pain and children’s oral health. In this episode of Over the Counter, HBW Insight catches up with Haleon vice president and general manager Great Britain and Ireland Bas Vorsteveld, to find out more about why having a purpo…
…
continue reading